Vident Investment Advisory’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$200K Buy
2022
Q3
Sell
2022
Q2
$374K Sell
2022
Q1
$453K Sell
2021
Q4
$434K Buy
2021
Q3
$253K Sell
2021
Q2
$471K Buy
2021
Q1
$260K Sell
2020
Q4
$266K Sell
2020
Q3
$226K Buy
2015
Q4
Sell
2015
Q3
$743K Buy